Try our mobile app

Published: 2023-11-29 16:30:59 ET
<<<  go to SNPS company page
EX-99.1 2 d613884dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

PRESS RELEASE

INVESTOR CONTACT:

Trey Campbell

Synopsys, Inc.

650-584-4289

Synopsys-ir@synopsys.com

EDITORIAL CONTACT:

Cara Walker

Synopsys, Inc.

650-584-5000

corp-pr@synopsys.com

Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2023

Results Summary

 

   

Record quarterly revenue of $1.599 billion, up approximately 25% year over year. Record fiscal-year revenue of $5.843 billion, up approximately 15% year over year.

 

   

Quarterly GAAP earnings per diluted share of $2.26; non-GAAP earnings per diluted share of $3.17, which exceeded high end of guidance. Fiscal year GAAP earnings per diluted share of $7.92; non-GAAP earnings per diluted share of $11.19, which exceeded high end of guidance.

SUNNYVALE, Calif. Nov. 29, 2023Synopsys, Inc. (Nasdaq: SNPS) today reported results for its fourth quarter and fiscal year 2023. Revenue for the fourth quarter of fiscal year 2023 was $1.599 billion, compared to $1.284 billion for the fourth quarter of fiscal year 2022. Revenue for fiscal year 2023 was $5.843 billion, an increase of approximately 15% from $5.082 billion in fiscal year 2022.

“In our 37 years as a company, Synopsys has driven a roughly 10 million-fold increase in chip design productivity. This not only enabled the exponential ambition of the semiconductor industry, it, in turn, radically impacted the world,” said Aart de Geus, chair and CEO of Synopsys. “Our momentum continued in 2023 as we substantially expanded our AI-driven design differentiation, our semiconductor IP portfolio, and our multi-die system solutions. We also visibly strengthened our customers’ differentiation through unique and deep collaborations. Looking ahead, I have great confidence, expectations, and enthusiasm for our future as Sassine Ghazi becomes Synopsys’ CEO.”

 

1


“Despite global macroeconomic uncertainty, 2023 was a year of record revenue and profitability for Synopsys as silicon R&D and design-starts remain robust. I want to extend my deepest thanks to our team for their stellar execution and to our partners and customers for their commitment,” said Sassine Ghazi, president and COO of Synopsys. “We start 2024 with tremendous forward momentum driven by a resilient business model, technology trends – chief among them AI – that create a rising tide for our business, and customers who continue to prioritize investments in the chips and systems that position them for the future. I am profoundly grateful for the opportunity to propel Synopsys to the next wave of growth as its CEO.”

“We had strong execution and outperformed our guidance in the fourth quarter, which capped a record financial year for Synopsys. In 2023, on a non-GAAP basis, record earnings per share were up 26% year-over-year, we achieved record operating margins, and expanded our backlog to $8.6 billion,” said Synopsys CFO, Shelagh Glaser. “We are confident in our outlook for continued, double-digit revenue growth in the year ahead based on our technology leadership, strong customer momentum and the resiliency of our time-based business model.”

GAAP Results

On a U.S. generally accepted accounting principles (GAAP) basis, net income for the fourth quarter of fiscal year 2023 was $349.2 million, or $2.26 per diluted share, compared to $153.5 million, or $0.99 per diluted share, for the fourth quarter of fiscal year 2022. GAAP net income for fiscal year 2023 was $1.230 billion, or $7.92 per diluted share, compared to $984.6 million, or $6.29 per diluted share, for fiscal year 2022.

Non-GAAP Results

On a non-GAAP basis, net income for the fourth quarter of fiscal year 2023 was $490.9 million, or $3.17 per diluted share, compared to non-GAAP net income of $297.7 million, or $1.91 per diluted share, for the fourth quarter of fiscal year 2022. Non-GAAP net income for fiscal year 2023 was $1.737 billion, or $11.19 per diluted share, compared to non-GAAP net income of $1.393 billion, or $8.90 per diluted share, for fiscal year 2022.

For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see “GAAP to Non-GAAP Reconciliation” in the accompanying tables below.

 

2


Business Segments

Synopsys reports revenue and operating income in three segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and field programmable gate array (FPGA) IC design software, verification software and hardware products, manufacturing software products and other; (2) Design IP, which includes our Design IP products; and (3) Software Integrity, which includes solutions that test software code for security vulnerabilities and quality defects, as well as professional and managed services. Further information regarding these segments is provided at the end of this press release.

Financial Targets

Synopsys also provided its consolidated financial targets for the first quarter and full fiscal year 2024. The fiscal year targets include the impact of an extra week in fiscal year 2024, which will be included in the first quarter of fiscal year 2024. These financial targets assume no further changes to export control restrictions or the current U.S. government “Entity List” restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see “Forward-Looking Statements” below.

First Quarter and Full Fiscal Year 2024 Financial Targets (1)

(in millions except per share amounts)

 

     Range for Three Months Ending
January 31, 2024
    Range for Fiscal Year Ending
October 31, 2024
 
     Low     High     Low     High  

Revenue

   $ 1,630     $ 1,660     $ 6,570     $ 6,630  

GAAP Expenses

   $ 1,217     $ 1,237     $ 4,995     $ 5,052  

Non-GAAP Expenses

   $ 1,017     $ 1,027     $ 4,140     $ 4,180  

Non-GAAP Other Income (Expense)

   $ —       $ 2     $ 4     $ 8  

Non-GAAP Tax Rate

     15     15     15     15

Outstanding Shares (fully diluted)

     155       157       155       157  

GAAP EPS

   $ 2.40     $ 2.50     $ 9.07     $ 9.25  

Non-GAAP EPS

   $ 3.40     $ 3.45     $ 13.33     $ 13.41  

Operating Cash Flow

         ~ $1,400  

 

(1)

Synopsys’ first quarter of fiscal year 2024 has one extra week and will end on February 3, 2024. Fiscal year 2024 will end on November 2, 2024. For presentation purposes, we refer to the closest calendar month end.

 

3


For a reconciliation of Synopsys’ first quarter and fiscal year 2024 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see “GAAP to Non-GAAP Reconciliation” in the accompanying tables below.

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys’ corporate website at www.investor.synopsys.com. Synopsys uses its website as a tool to disclose important information about Synopsys and comply with its disclosure obligations under Regulation Fair Disclosure. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the first quarter of fiscal year 2024 in February 2024.

Effectiveness of Information

The targets included in this press release, the statements made during the earnings conference call, the information contained in the financial supplement and the corporate overview presentation, each of which are available on Synopsys’ corporate website at www.synopsys.com (collectively, the “Earnings Materials”), represent Synopsys’ expectations and beliefs as of November 29, 2023. Although these Earnings Materials will remain available on Synopsys’ website through the date of the earnings call for the first quarter of fiscal year 2024, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

Availability of Final Financial Statements

Synopsys will include final financial statements for the fiscal year 2023 in its annual report on Form 10-K to be filed on or before December 27, 2023.

 

4


About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry’s broadest portfolio of application security testing tools and services. Whether you’re a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at www.synopsys.com.

GAAP to Non-GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP, but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys’ operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. These non-GAAP measures may be different from non-GAAP measures used by other companies. Synopsys’ management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, as superior to, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys’ management believes it is useful for itself and investors to review, as applicable, both GAAP financial measures that include: (i) the amortization of acquired intangible assets, (ii) the impact of stock compensation, (iii) acquisition-related items, (iv) restructuring charges, (v) the effects of certain settlements, final judgments and loss contingencies related to legal proceedings, and (vi) the income tax effect of non-GAAP pre-tax adjustments, in each case as described further in Item 2.02 of Synopsys’ Current Report on Form 8-K filed on November 29, 2023. In addition, the non-GAAP financial measures that exclude such information help facilitate internal comparisons to Synopsys’ historical operating results and forecasted targets, planning and forecasting in subsequent periods and comparisons to competitors’ operating results.

Synopsys utilizes an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect Synopsys’ normal operations, and to more closely align its tax rate with its expected geographic earnings mix. This annual non-GAAP tax rate is based on an evaluation of

 

5


Synopsys’ historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives. Based on these considerations, Synopsys has elected to adopt a non-GAAP tax rate of 15% for fiscal year 2024.

When possible, Synopsys provides a reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below, as well as Item 2.02 of Synopsys’ Current Report on Form 8-K filed on November 29, 2023, for additional information about the measures Synopsys uses to evaluate its core business operations. Synopsys is unable to provide a reconciliation of certain non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis because doing so would not be possible without unreasonable effort due to, among other things, the potential variability and limited visibility of the excluded items. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information.

Reconciliation of Fourth Quarter and Fiscal Year 2023 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per diluted share for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Fourth Quarter Fiscal Year 2023 Results(1)

(unaudited and in thousands, except per share amounts)

 

     Three Months Ended
October 31,
     Twelve Months Ended
October 31,
 
     2023      2022      2023      2022  

GAAP net income attributed to Synopsys

   $ 349,190      $ 153,500      $ 1,229,888      $ 984,594  

Adjustments:

           

Amortization of intangible assets

     26,949        25,530        98,790        95,711  

Stock compensation

     140,989        125,339        561,928        458,776  

Acquisition-related items

     5,269        (2,063      15,115        9,269  

Restructuring charges

     (1,382      —          77,002        12,057  

Tax settlement

     —          —          (23,752      —    

Tax adjustments

     (30,072      (4,618      (222,204      (167,582
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income attributed to Synopsys

   $ 490,943      $ 297,688      $ 1,736,767      $ 1,392,825  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

6


     Three Months Ended
October 31,
     Twelve Months Ended
October 31,
 
     2023      2022      2023      2022  

GAAP net income per diluted share attributed to Synopsys

   $ 2.26      $ 0.99      $ 7.92      $ 6.29  

Adjustments:

           

Amortization of intangible assets

     0.17        0.16        0.64        0.61  

Stock compensation

     0.91        0.80        3.62        2.93  

Acquisition-related items

     0.03        (0.01      0.10        0.06  

Restructuring charges

     (0.01      —          0.50        0.08  

Tax settlement

     —          —          (0.15      —    

Tax adjustments

     (0.19      (0.03      (1.44      (1.07
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income per diluted share attributed to Synopsys

   $ 3.17      $ 1.91      $ 11.19      $ 8.90  
  

 

 

    

 

 

    

 

 

    

 

 

 

Shares used in computing net income per diluted share amounts:

     154,845        155,749        155,195        156,485  

 

(1)

Synopsys’ fourth quarter of fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

GAAP to Non-GAAP Tax Rate Reconciliation (1)

(unaudited)

 

     Twelve Months Ended
October 31, 2023
 

GAAP effective tax rate

     6.4

Stock compensation

     3.3

Tax settlement

     1.8

Tax adjustments (2)

     4.5
  

 

 

 

Non-GAAP effective tax rate

     16.0
  

 

 

 

 

(1)

Synopsys’ fiscal year 2023 ended on October 28, 2023. For presentation purposes, we refer to the closest calendar month end.

(2)

The adjustments are primarily related to the differences in the tax rate effect of certain deductions, such as the deduction for foreign-derived intangible income and credits.

Reconciliation of 2024 Targets

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

 

7


GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2024 Targets (1)

(in thousands, except per share amounts)

 

     Range for Three Months Ending
January 31, 2024
 
     Low      High  

Target GAAP expenses

   $ 1,217,000      $ 1,237,000  

Adjustments:

     

Amortization of intangible assets

     (26,000      (29,000

Stock compensation

     (174,000      (181,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 1,017,000      $ 1,027,000  
  

 

 

    

 

 

 
     Range for Three Months Ending
January 31, 2024
 
     Low      High  

Target GAAP earnings per diluted share attributed to Synopsys

   $ 2.40      $ 2.50  

Adjustments:

     

Amortization of intangible assets

     0.19        0.17  

Stock compensation

     1.16        1.12  

Tax adjustments

     (0.35      (0.34
  

 

 

    

 

 

 

Target non-GAAP earnings per diluted share attributed to Synopsys

   $ 3.40      $ 3.45  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     156,000        156,000  

GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2024 Targets (1)

(in thousands, except per share amounts)

 

     Range for Fiscal Year Ending
October 31, 2024
 
     Low      High  

Target GAAP expenses

   $ 4,995,000      $ 5,052,000  

Adjustments:

     

Amortization of intangible assets

     (103,000      (108,000

Stock compensation

     (752,000      (764,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 4,140,000      $ 4,180,000  
  

 

 

    

 

 

 

 

8


     Range for Fiscal Year Ending
October 31, 2024
 
     Low      High  

Target GAAP earnings per diluted share attributed to Synopsys

   $ 9.07      $ 9.25  

Adjustments:

     

Amortization of intangible assets

     0.69        0.66  

Stock compensation

     4.90        4.82  

Tax adjustments

     (1.33      (1.32
  

 

 

    

 

 

 

Target non-GAAP earnings per diluted share attributed to Synopsys

   $ 13.33      $ 13.41  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     156,000        156,000  

 

(1)

Synopsys’ first quarter of fiscal year 2024 has one extra week and will end on February 3, 2024. Fiscal year 2024 will end on November 2, 2024. For presentation purposes, we refer to the closest calendar month end.

Forward-Looking Statements

This press release and the investor conference call contain forward-looking statements, including, but not limited to, statements regarding Synopsys’ executive management transition, short-term and long-term financial targets, expectations and objectives; strategies related to our products, technology and services; business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence; the expected impact of U.S. and foreign government actions and regulatory changes, including export control restrictions on our financial results; the potential impact of the uncertain macroeconomic and geopolitical environment on our financial results; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; software trends; planned acquisitions and stock repurchases; our expected tax rate; and the impact and result of pending legal, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and geopolitical uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys’ results is included in filings we make

 

9


with the SEC from time to time, including in the sections entitled “Risk Factors” in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys’ most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. Synopsys’ financial results for its fourth quarter and fiscal year 2023 are not necessarily indicative of Synopsys’ operating results for any future periods. The information provided herein is as of November 29, 2023. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

 

10


SYNOPSYS, INC.

Unaudited Consolidated Statements of Income (1)

(in thousands, except per share amounts)

 

     Three Months Ended
October 31,
    Twelve Months Ended
October 31,
 
     2023     2022     2023     2022  

Revenue:

        

Time-based products

   $ 870,249     $ 808,160     $ 3,383,632     $ 2,993,786  

Upfront products

     449,181       253,245       1,429,330       1,226,728  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total products revenue

     1,319,430       1,061,405       4,812,962       4,220,514  

Maintenance and service

     279,698       222,887       1,029,657       861,028  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     1,599,128       1,284,292       5,842,619       5,081,542  

Cost of revenue:

        

Products

     213,586       173,617       763,494       653,783  

Maintenance and service

     98,779       89,313       383,835       342,978  

Amortization of intangible assets

     19,978       19,791       74,864       66,936  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenue

     332,343       282,721       1,222,193       1,063,697  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     1,266,785       1,001,571       4,620,426       4,017,845  

Operating expenses:

        

Research and development

     488,485       461,618       1,946,813       1,680,379  

Sales and marketing

     228,982       208,448       889,016       779,777  

General and administrative

     112,150       107,414       410,311       353,840  

Amortization of intangible assets

     8,029       6,718       28,025       29,754  

Restructuring charges

     (1,382     —         77,002       12,057  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     836,264       784,198       3,351,167       2,855,807  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     430,521       217,373       1,269,259       1,162,038  

Other income (expense), net

     (20,830     (5,244     32,523       (46,524
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     409,691       212,129       1,301,782       1,115,514  

Provision (benefit) for income taxes

     63,196       60,572       83,657       137,078  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     346,495       151,557       1,218,125       978,436  

Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest

     (2,695     (1,943     (11,763     (6,158
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributed to Synopsys

   $ 349,190     $ 153,500     $ 1,229,888     $ 984,594  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share attributed to Synopsys:

        

Basic

   $ 2.30     $ 1.00     $ 8.08     $ 6.44  

Diluted

   $ 2.26     $ 0.99     $ 7.92     $ 6.29  

Shares used in computing per share amounts:

        

Basic

     151,972       152,761       152,146       153,002  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     154,845       155,749       155,195       156,485  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Synopsys’ fourth quarter of fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

 

11


SYNOPSYS, INC.

Unaudited Consolidated Balance Sheets (1)

(in thousands, except par value amounts)

 

     October 31, 2023     October 31, 2022  

ASSETS:

    

Current assets:

    

Cash and cash equivalents

   $ 1,438,913     $ 1,417,608  

Short-term investments

     151,639       147,913  
  

 

 

   

 

 

 

Total cash, cash equivalents and short-term investments

     1,590,552       1,565,521  

Accounts receivable, net

     946,967       796,091  

Inventories

     325,590       211,927  

Prepaid and other current assets

     567,515       439,130  
  

 

 

   

 

 

 

Total current assets

     3,430,624       3,012,669  

Property and equipment, net

     557,261       483,300  

Operating lease right-of-use assets, net

     568,829       559,090  

Goodwill

     4,070,336       3,842,234  

Intangible assets, net

     374,194       386,446  

Deferred income taxes

     860,914       670,653  

Other long-term assets

     470,973       463,695  
  

 

 

   

 

 

 

Total assets

   $ 10,333,131     $ 9,418,087  
  

 

 

   

 

 

 

LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY:

    

Current liabilities:

    

Accounts payable and accrued liabilities

   $ 1,123,761     $ 809,403  

Operating lease liabilities

     85,690       54,274  

Deferred revenue

     1,776,000       1,910,822  
  

 

 

   

 

 

 

Total current liabilities

     2,985,451       2,774,499  

Long-term operating lease liabilities

     584,035       581,273  

Long-term deferred revenue

     175,128       154,472  

Long-term debt

     18,078       20,824  

Other long-term liabilities

     386,138       327,829  
  

 

 

   

 

 

 

Total liabilities

     4,148,830       3,858,897  
  

 

 

   

 

 

 

Redeemable non-controlling interest

     31,043       38,664  

Stockholders’ equity:

    

Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

     —         —    

Common stock, $0.01 par value: 400,000 shares authorized; 152,053 and 152,375 shares outstanding, respectively

     1,521       1,524  

Capital in excess of par value

     1,276,152       1,487,126  

Retained earnings

     6,741,699       5,534,307  

Treasury stock, at cost: 5,207 and 4,886 shares, respectively

     (1,675,650     (1,272,955

Accumulated other comprehensive income (loss)

     (196,414     (234,277
  

 

 

   

 

 

 

Total Synopsys stockholders’ equity

     6,147,308       5,515,725  

Non-controlling interest

     5,950       4,801  
  

 

 

   

 

 

 

Total stockholders’ equity

     6,153,258       5,520,526  
  

 

 

   

 

 

 

Total liabilities, redeemable non-controlling interest and stockholders’ equity

   $ 10,333,131     $ 9,418,087  
  

 

 

   

 

 

 

 

(1)

Synopsys’ fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

 

12


SYNOPSYS, INC.

Unaudited Condensed Consolidated Statements of Cash Flows (1)

(in thousands)

 

     Twelve Months Ended October 31,  
     2023     2022  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net income

   $ 1,218,125     $ 978,436  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Amortization and depreciation

     247,120       228,405  

Reduction of operating lease right-of-use assets

     97,705       89,541  

Amortization of capitalized costs to obtain revenue contracts

     82,190       73,026  

Stock-based compensation

     563,292       459,029  

Allowance for credit losses

     19,932       (3,477

Deferred income taxes

     (211,045     (36,913

Other non-cash

     13,295       10,188  

Net changes in operating assets and liabilities, net of acquired assets and assumed liabilities:

    

Accounts receivable

     (178,432     (251,390

Inventories

     (123,752     1,320  

Prepaid and other current assets

     (106,396     (89,983

Other long-term assets

     (100,618     (15,283

Accounts payable and accrued liabilities

     170,496       (34,066

Operating lease liabilities

     (73,281     (85,828

Income taxes

     198,078       1,644  

Deferred revenue

     (113,435     414,251  
  

 

 

   

 

 

 

Net cash provided by operating activities

     1,703,274       1,738,900  

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Proceeds from sales and maturities of short-term investments

     130,435       93,696  

Purchases of short-term investments

     (131,079     (97,245

Proceeds from sales of long-term investments

     8,492       582  

Purchases of long-term investments

     (435     (7,000

Purchases of property and equipment

     (189,618     (136,589

Acquisitions, net of cash acquired

     (297,692     (422,374

Capitalization of software development costs

     (2,204     (2,493

Other

     —         (1,200
  

 

 

   

 

 

 

Net cash used in investing activities

     (482,101     (572,623

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Repayment of debt

     (2,603     (76,838

Issuances of common stock

     252,986       237,956  

Payments for taxes related to net share settlement of equity awards

     (241,408     (174,005

Purchase of equity forward contract

     (45,000     —    

Purchases of treasury stock

     (1,160,724     (1,100,000

Other

     (122     (3,413
  

 

 

   

 

 

 

Net cash used in financing activities

     (1,196,871     (1,116,300

Effect of exchange rate changes on cash, cash equivalents and restricted cash

     (2,979     (65,296
  

 

 

   

 

 

 

Net change in cash, cash equivalents and restricted cash

     21,323       (15,319

Cash, cash equivalents and restricted cash, beginning of year

     1,419,864       1,435,183  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period

   $ 1,441,187     $ 1,419,864  
  

 

 

   

 

 

 

 

(1)

Synopsys’ fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

 

13


SYNOPSYS, INC.

Business Segment Reporting (1)(2)

(in millions)

 

    Three Months Ended
October 31, 2023
    Three Months Ended
October 31, 2022
    Twelve Months Ended
October 31, 2023
    Twelve Months Ended
October 31, 2022
 

Revenue by segment

       

- Design Automation

  $ 953.7     $ 862.1     $ 3,775.3     $ 3,300.2  

% of Total

    59.7     67.1     64.6     64.9

- Design IP

  $ 513.7     $ 295.2     $ 1,542.7     $ 1,315.5  

% of Total

    32.1     23.0     26.4     25.9

- Software Integrity

  $ 131.7     $ 127.1     $ 524.6     $ 465.8  

% of Total

    8.2     9.9     9.0     9.2

Total segment revenue

  $ 1,599.1     $ 1,284.3     $ 5,842.6     $ 5,081.5  

Adjusted operating income by segment

       

- Design Automation

  $ 317.9     $ 294.7     $ 1,439.7     $ 1,206.6  

- Design IP

  $ 241.4     $ 48.1     $ 532.1     $ 421.5  

- Software Integrity

  $ 20.0     $ 10.7     $ 76.3     $ 47.0  

Total adjusted segment operating income

  $ 579.4     $ 353.4     $ 2,048.0     $ 1,675.1  

Adjusted operating margin by segment

       

- Design Automation

    33.3     34.2     38.1     36.6

- Design IP

    47.0     16.3     34.5     32.0

- Software Integrity

    15.2     8.4     14.5     10.1

Total adjusted segment operating margin

    36.2     27.5     35.1     33.0

Total Adjusted Segment Operating Income Reconciliation (1)(2)(3)

(in millions)

 

     Three Months Ended
October 31, 2023
    Three Months Ended
October 31, 2022
    Twelve Months Ended
October 31, 2023
     Twelve Months Ended
October 31, 2022
 

GAAP total operating income – as reported

   $ 430.5     $ 217.4     $ 1,269.3      $ 1,162.0  

Other expenses managed at consolidated level

         

-Amortization of intangible assets (4)

     28.0       26.5       102.9        96.7  

-Stock compensation (4)

     141.3       125.6       563.3        459.0  

-Non-qualified deferred compensation plan

     (24.4     (18.8     20.5        (68.8

-Acquisition-related items (5)

     5.3       2.7       15.1        14.1  

-Restructuring charges

     (1.4     —         77.0        12.1  
  

 

 

   

 

 

   

 

 

    

 

 

 

Total adjusted segment operating income

   $ 579.4     $ 353.4     $ 2,048.0      $ 1,675.1  
  

 

 

   

 

 

   

 

 

    

 

 

 

 

(1)

Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our business. Amounts may not foot due to rounding.

(2)

Synopsys’ fourth quarter of fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

(3)

These segments results are consistent with the information required by ASC 280, Segment Reporting. Synopsys’ chief operating decision maker (CODM) is our Chief Executive Officer. The CODM does not allocate certain operating expenses managed at a consolidated level to our reportable segments and, as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table above.

(4)

The adjustment includes non-GAAP expenses attributable to non-controlling interest and redeemable non-controlling interest.

(5)

The adjustment excludes the gains from the mark-up of a cost method investment to fair value upon obtaining control through the acquisition recorded in other income (expense).

 

14